» Articles » PMID: 18591623

Molecular Characterization of Acute Myeloid Leukemia

Overview
Journal Haematologica
Specialty Hematology
Date 2008 Jul 2
PMID 18591623
Citations 50
Authors
Affiliations
Soon will be listed here.
Citing Articles

Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia.

Forte D, Pellegrino R, Falvo P, Garcia-Gonzalez P, Alabed H, Maltoni F Nat Commun. 2024; 15(1):10878.

PMID: 39738118 PMC: 11685939. DOI: 10.1038/s41467-024-55231-9.


Prioritization of Eleven-Nineteen-Leukemia Inhibitors as Orally Available Drug Candidates for Acute Myeloid Leukemia.

Guo X, Atla S, Nyalata S, Alugubelli Y, Chen P, Xu S J Med Chem. 2024; 67(22):20100-20117.

PMID: 39530508 PMC: 11613437. DOI: 10.1021/acs.jmedchem.4c01337.


Exploring the Prevalence and Prognostic Impact of Wilms Tumor 1 Exon 7 Mutation Status with Combinations of FLT3-ITD and NPM1 Mutations as Potential Molecular Biomarkers in Acute Myeloid Leukemia Patients with Normal Cytogenetics.

Anitha G, Chandraprabha V, Padmakumar D, Sreelatha M, Padmakumar A, Gopinath P Asian Pac J Cancer Prev. 2024; 25(10):3463-3470.

PMID: 39471012 PMC: 11711371. DOI: 10.31557/APJCP.2024.25.10.3463.


Validation and refinement of the 2022 European LeukaemiaNet genetic risk classification of acute myeloid leukaemia patients receiving allogeneic haematopoietic cell transplantation.

Chen W, Chen L, Cao Y, Jiang C, Luo Y, Ouyang G Leukemia. 2024; 38(12):2712-2716.

PMID: 39468195 DOI: 10.1038/s41375-024-02440-2.


Identification of Novel DNA Methylation Prognostic Biomarkers for AML With Normal Cytogenetics.

Cardoso C, Pestana D, Gokuladhas S, Marreiros A, OSullivan J, Binnie A JCO Clin Cancer Inform. 2024; 8:e2300265.

PMID: 39052947 PMC: 11371081. DOI: 10.1200/CCI.23.00265.